Clinical Trial Update: Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating sublingual misoprostol to decrease blood loss prior to myomectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids Associated Myomectomy Blood Loss May Be Related Condition

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Assiut University | Conditions: Blood Loss in Myomectomy | Phase 3 | Status: COMPLETED